期刊文献+

曲古霉素对卵巢癌细胞体外增殖与凋亡能力的影响及其分子机制研究 被引量:2

Effects of trichomycin on proliferation and apoptosis of ovarian cancer cells in vitro and its molecular mechanisms
原文传递
导出
摘要 目的研究曲古霉素对卵巢癌细胞增殖、凋亡能力的影响及机制。方法将卵巢癌SKOV-3细胞分为空白组(生理盐水)、对照组(10μg·m L-1顺铂)和低、中、高剂量实验组(1.0,1.5,2.0μmol·L-1曲古霉素)。以噻唑蓝(MTT)检测细胞增殖情况,以Hoechst 33258核染色法检测细胞凋亡,以JC-1染色法检测细胞线粒体膜电位(MMP),以蛋白质印迹法(WB)检测细胞凋亡相关蛋白的表达。结果空白组、对照组和低、中、高剂量实验组凋亡率分别为(1.26±0.35)%,(25.48±2.52)%,(22.65±2.67)%,(29.15±3.34)%,(58.25±3.93)%,MMP分别为1.00±0.00,0.72±0.15,0.80±0.05,0.62±0.07,0.51±0.05,Caspase-3蛋白相对表达量为1.46±0.25,0.48±0.06,1.32±0.16,0.85±0.11,0.35±0.09,p53蛋白相对表达量为1.58±0.33,0.63±0.21,1.46±0.29,1.05±0.16,0.58±0.14,Bax蛋白相对表达量为0.56±0.12,0.91±0.05,0.89±0.22,0.92±0.15,1.32±0.20,Bcl2蛋白相对表达量为0.93±0.14,0.46±0.02,0.71±0.05,0.62±0.03,0.56±0.04,差异均有统计学意义(均P<0.05)。结论曲古霉素可抑制卵巢癌细胞的增殖,通过调控凋亡通路相关蛋白及线粒体凋亡途径诱导癌细胞凋亡,且与干预剂量相关。 Objective To investigate the effect and mechanism of trichomycin on proliferation and apoptosis of ovarian cancer cells.Methods SKOV-3 cells of ovarian cancer were divided into blank group(treated with saline),control group(10μg·mL-1cisplatin)and low,middle,high dose experimental groups(treated with trichomycin of 1.0,1.5,2.0μg·mL-1).Cell proliferation inhibition and apoptosis were detected by MTT and Hoechst 33258 nuclear staining respectively.Mitochondrial membrane potential(MMP)were detected by by JC-1 staining;the expression of apoptosis-related protein were detected by Western blot(WB).Results The apoptotic rates of blank group,control group and low,middle,high dose experimental groups were(1.26±0.35)%,(25.48±2.52)%,(22.65±2.67)%,(29.15±3.34)%,(58.25±3.93)%,MMP were 1.00±0.00,0.72±0.15,0.80±0.05,0.62±0.07,0.51±0.05,the relative expression of protein Caspase-3 were 1.46±0.25,0.48±0.06,1.32±0.16,0.85±0.11,0.35±0.09,the relative expression of protein p53 were 1.58±0.33,0.63±0.21,1.46±0.29,1.05±0.16,0.58±0.14,the relative expression of protein Bax were 0.56±0.12,0.91±0.05,0.89±0.22,0.92±0.15,1.32±0.20,the relative expression of protein Bcl2 were 0.93±0.14,0.46±0.02,0.71±0.05,0.62±0.03,0.56±0.04,the difference was all statistically significant(all P<0.05).Conclusion Trichomycin can inhibit the proliferation of ovarian cancer cells,induce apoptosis by regulating apoptotic pathway related proteins and mitochondrial apoptotic pathways,and is related to the intervention dose.
作者 王小蓉 程艳香 彭晓蓉 肖华 谢丽芳 WANG Xiao-rong;CHENG Yan-xiang;PENG Xiao-rong;XIAO Hua;XIE Li-fang(Department of Obstetrics and Gynaecology,Hubei Province People’s Hospital of Public Security County,Jingzhou 434300,Hubei Province,China;Department of Laboratory,Hubei Province People’s Hospital of Public Security County,Jingzhou 434300,Hubei Province,China;Department of Oncology,Hubei Province People’s Hospital of Public Security County,Jingzhou 434300,Hubei Province,China;Department of Gynecology,People’s Hospital of Wuhan University,Wuhan 430060,Hubei Province,China;Department of Oncology,Jingzhou First People’s Hospital,Jingzhou 434000,Hubei Province,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2019年第17期1909-1911,1916,共4页 The Chinese Journal of Clinical Pharmacology
关键词 卵巢癌 曲古霉素 增殖 凋亡 线粒体膜电位 ovarian cancer trichomycin proliferation apoptosis mitochondrial membrane potential
  • 相关文献

参考文献9

二级参考文献101

  • 1李宏建,李贵海,孙付军,尹格平.苦参碱对肿瘤细胞获得性多药耐药的逆转作用[J].中国医院药学杂志,2005,25(5):389-391. 被引量:13
  • 2张雯碧,鹿欣.卵巢癌化疗耐药相关基因与预后的研究进展[J].国外医学(妇产科学分册),2007,34(3):193-196. 被引量:16
  • 3Lenz H. Clinical update: proteasome inhibitors in solid tumors [J]. Cancer Treat. Rev,2003,29(Suppl 1 ) :41-48.
  • 4Groll M, Berkers CR, Ploegh HI., et al. Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome[J]. Structure, 2006 , 14 (3) :451-456.
  • 5Julian A. Development of the Proteasome Inhibitor PS-341[J]. The Oncologist, 2002,7:9-16.
  • 6LeBlanc R, Catley I.P, Hideshima T, etal. Proteasome inhibitor PS341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model[J]. Cancer Res, 2002, 62 (17) : 4996-5000.
  • 7Mitsiades N, Mitsiades CS, Richardson PG, et al. The proteasome in-hibitor PS2341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications[J]. Blood, 2003,101 (6) :2377-2380.
  • 8Cusack JC,Rong L, Houston M, et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor P8-341: implications for systemic nuclear facto-kB inhibition[J]. Cancer Res, 2001,61 :3535- 3540.
  • 9Teicher BA,Ara G, Herbst R, et al. The proteasome inhibitor PS-341 in cancer therapy[J]. Clin Cancer Res, 1999,5 : 2638- 2645.
  • 10Li QQ, Yunmbam MK,Zhong X, et al. Laetacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ER-CC-1 expression[J]. Cell Mol Biol (Noisy le-grand), 2001,47:61-72.

共引文献28

同被引文献24

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部